Moderna | This Week in Virology

Vincent and Brianne review the need to better understand T cell responses to SARS-CoV-2 infection to better inform public health decisions, and how IL-1 and IL-1ra are important regulators of the inflammatory response to RNA vaccines.

TWiV 827: A shot to save the world with Greg Zuckerman

November 7, 2021
Tagged as: adenovirus vector, BioNTech, coronavirus, COVID-19, Moderna, mRNA vaccine, Novavax, pandemic, Pfizer, SARS-CoV-2, Vaccine, viral, virology, virus, viruses

Greg Zuckerman joins TWiV to discuss his book that explores the race to produce COVID-19 vaccines, with insights into the companies, scientists, and executives involved and the rivalries, ambitions, ego, and a desire to save the world.

Netcast

TWiV 642: Bringin’ in 50 keys of spike mRNA

July 19, 2020
Tagged as: comorbidities, COVID-19, Moderna, mRNA vaccine, OpenSafely, pandemic, SARS-CoV-2, viral, virology, virus, viruses

Daniel Griffin provides a clinical update on COVID-19, then we discuss phase I preliminary results of the SARS-CoV-2 mRNA vaccine, factors associated with death in 17 million patients, and answer listener questions.

TWiV 616: Singing about coronavirus

May 21, 2020
Tagged as: ACE2, chorus, cigarette smoke, COVID-19, Moderna, mRNA vaccine, pandemic, SARS-CoV-2, viral, virology, virus, viruses

Vincent, Kathy and Rich discuss COVID-19 research paper overload, Moderna’s mRNA vaccine Phase I results, increase of ACE2 RNA by cigarette smoke, and answer listener questions.

Tag: Moderna

TWiV 882: Elispot on about T cells and lipids

TWiV 827: A shot to save the world with Greg Zuckerman

TWiV 642: Bringin’ in 50 keys of spike mRNA

TWiV 616: Singing about coronavirus

Search

Questions or comments

Contribute

Inside a BSL-4 laboratory